Tropical causes of epilepsy;Causas tropicales de epilepsia

Revista de Neurologia

Volumn 49, Issue 9, 2009, Pages 475-482

  Carod Artal, Francisco Javier ^a  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

Author keywords

Cerebral malaria; Epilepsy; Helminthiasis; Neurocysticercosis; Schistosomiasis; Tropics

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTICESTODAL AGENT; ANTICONVULSIVE AGENT; ANTIMALARIAL AGENT; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRAZIQUANTEL; PREDNISOLONE; PREDNISONE; QUININE;

ABDOMINAL PAIN; ADULTHOOD; AFRICAN TRYPANOSOMIASIS; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION; BRAIN MALARIA; BRAIN PSEUDOTUMOR; CENTRAL NERVOUS SYSTEM; CHAGAS DISEASE; CLINICAL TRIAL; COMA; CYST; CYSTICERCUS (CESTODE LARVA); DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG METABOLISM; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EPILEPSY; EPILEPTOGENESIS; FEVER; FOCAL EPILEPSY; GRANULOMA; HUMAN; INFECTION CONTROL; IRRITABILITY; MIGRAINE; NAUSEA; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; NEUROSCHISTOSOMIASIS; PARASITOSIS; PATHOPHYSIOLOGY; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SCHISTOSOMA JAPONICUM; SEIZURE; SIDE EFFECT; SPARGANOSIS; SYMPTOM; SYSTEMIC DISEASE; TOXOCARIASIS; TREATMENT DURATION; TROPICS;

EID: 73949126553     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4909.2009212     Document Type: Review

References (62)

1. Kotsopoulos IA, Van Merode T, Kessels FG, De Krom MC, Knottneurs JA. Systematic review and meta-analysis of incidence studies and unprovoked seizures. Epilepsia 2002; 43: 1402-9.
2. Del Brutto OH, Carod-Artal FJ, Román G, Senanayake N. Tropical neurology. In American Academy of Neurology, ed. Continuum. Vol. 8. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 36-49.
3. Carod-Artal FJ, Vázquez-Cabrera CB. An anthropological study about epilepsy in native tribes from Central and South America. Epilepsia 2007; 48: 886-93.
4. Carod-Artal FJ. Bolivia. In D'Avanzo C, ed. Mosby's pocket guide to cultural health assessment. 4 ed. Saint Louis: Mosby; 2008. p. 83-8.
5. Dumas M, Preux PM. Épilepsie en zone tropicale. Bull Acad Natl Med 2008; 192: 949-60.
6. Prasad KN, Prasad A, Gupta RK, Pandey CM, Singh U. Prevalence and associated risk factors of Taenia solium taeniasis in a rural pig farming community of north India. Trans R Soc Trop Med Hyg 2007; 101: 1241-7.
7. Tarabini-Castellani P, González-Chinchón G, Aldamiz-Echebarría M, Portu-Zapirain J, Apraiz-Garmendia L, Álvarez de Arcaya A. Neuroesquistosomiasis: un reto para el diagnóstico. Rev Neurol 2007; 44: 154-6.
8. Más-Sesé G, Vives-Piñera I, Fernández-Barreiro A, Martínez-Lage JF, Martínez-Salcedo E, Alarcón- Martínez H, et al. Estudio descriptivo de neurocisticercosis en un hospital terciario. Rev Neurol 2008; 46: 194-6.
9. Del Brutto OH, Santibanez R, Idrovo L, Rodríguez S, Díaz-Calderón E, Navas C, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-todoor survey in rural coastal Ecuador. Epilepsia 2005; 46: 583-7.
10. Medina MT, Durón RM, Martínez L, Osorio JR, Estrada AL, Zúñiga C, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study. Epilepsia 2005; 46: 124-31.
11. Nicoletti A, Bartoloni A, Sofia V, Bartalesi F, Chávez JR, Osinaga R, et al. Epilepsy and neurocysticercosis in rural Bolivia: a populationbased survey. Epilepsia 2005; 46: 1127-32.
12. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, et al; EMERGEncy ID NET Study Group. Neurocysticercosis in radiographically imaged seizure patients in US emergency departments. Emerg Infect Dis 2002; 8: 608-13.
13. Singh P, Singhi S. Neurocysticercosis in children. J Clin Neurol 2004; 19: 482-92.
14. Carod-Artal FJ. Ictus de causa infecciosa en el trópico. Rev Neurol 2007; 44: 755-63.
15. Nash TE, White AC, Rajshekhar V, Loeb JA, Proaño JV, Takayanugui OM, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 2006; 67: 1120-7.
16. Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004; 62: 1934-8.
17. Nash TE, Pretell EJ, Lezcano AG, Busto JA, Gilman RH, González AE, et al; Cysticercosis Working Group in Peru. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008; 7: 1099-105.
18. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Privy Council Medical Research Special Report Series 1961; 229: 1-58.
19. MacArthur WP. Cysticercosis as seen in the British Army, with special reference to the production of epilepsy. Trans R Soc Trop Med Hyg 1934; 27: 343-63.
20. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991; 164: 1007-9.
21. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006; 145: 43-51.
22. Díaz Granados-Sánchez JA, Barrios-Arrazola G, Costa JL, Burbano-Pabón J, Pinzón-Bedoya J. Ivermectina como alternativa terapéutica en neurocisticercosis resistente al tratamiento farmacológico convencional. Rev Neurol 2008; 46: 671-4.
23. Carpio A, Allen-Hauser W. Prognosis for recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-4.
24. García HH, Pretell EJ, Gilman RH, Martínez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350: 249-58.
25. Mazumdar M, Pandharipande P, Poduri A. Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A systematic review and meta-analysis. J Child Neurol 2007; 22: 135-42.
26. Carpio A, Kelvin EA, Baguella E, Leslie D, Leon P, Andrews H, et al; Ecuadorian Neurocysticercosis Group. Effect of albendazole treatment on neurocysticercosis: a randomized controlled trail. J Neurol Neurosurg Psychiatry 2008; 79: 1050-5.
27. Garg RK, Potluri N, Kar AM, Singh MK, Shukla R, Agrawal A. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 2006; 53: 65-9.
28. Singhi P, Jain V, Khandelwal N. Corticoids versus albendazol for treatment of single small enhancing computed tomography lesions in children with neurocysticercosis. J Child Neurol 2004; 19: 323-7.
29. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003; 143: 111-4.
30. Thussu A, Chattopadhyay A, Sawhuey IM, Khandeford N. Albendazol therapy for single small enhancing CT lesion (SSECTL) in the brain in epilepsy. J Neurol Neurosurg Psychiatry 2008; 79: 271-5.
31. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998; 17: 696-700.
32. Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003; 97: 416-21.
33. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 2003; 44: 1397-401.
34. Prakash S, Garg RK, Kar AM, Shukla R, Agarwal A, Verma R, et al. Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: a random evaluation. Seizure 2006; 15: 328-32.
35. Bittencourt PRM, Garcia CM, Martins R, Fernandes AG, Diekmann HW, Jung W. Phenytoin and carbamazepine decrease oral bioavailability of praziquantel. Neurology 1992; 42: 492-6.
36. Lanchote VL, Garcia FS, Dreossi SAC, Takayanagui OM. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and anti-epileptic drugs in patients with neurocysticercosis. Ther Drug Monit 2002; 24: 338-45.
37. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004; 62: 2236-40.
38. Verma A, Misra S. Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol Scand 2006; 113: 174-7.
39. Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008; 102: 107-16.
40. Carod Artal FJ, Vargas AP, Horan TA, Marinho PB, Coelho-Costa PH. Schistosoma mansoni myelopathy: clinical and pathologic findings. Neurology 2004; 63: 388-91.
41. Jaureguiberry S, Ansart S, Perez L, Danis M, Bricaire F, Caumes E. Acute neuroschistosomiasis: two cases associated with cerebral vasculitis. Am J Trop Med Hyg 2007; 76: 964-6.
42. Silva JC, Lima FM, Vidal CH, Azevedo-Filho HC. Schistosomiasis mansoni presenting as a cerebellar tumor: case report. Arq Neuropsiquiatr 2007; 65: 845-7.
43. Betting LE, Pirani Jr C, De Souza-Queiroz L, Damasceno BP, Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol 2005; 62: 1008-10.
44. Preidler KW, Riepl T, Szolar D, Ranner G. Cerebral schistososmiasis: MR and CT appearance. AJNR Am J Neuroradiol 1996; 17: 1598-600.
45. Liu H, Lim CC, Feng X, Yao Z, Chen Y, Sun H, et al. MRI in cerebral schistosomiasis: characteristic nodular enhancement in 33 patients. AJR Am J Roentgenol 2008; 191: 582-8.
46. Artal FJ, Mesquita HM, Gepp RA, Antunes JS, Kalil RH. Brain involvement in a Schistosoma mansoni myelopathy patient. J Neurol Neurosurg Psychiatry 2006; 77: 512.
47. Lei T, Shu K, Chen X, Li L. Surgical treatment of epilepsy with chronic cerebral granuloma caused by Schistosoma japonicum. Epilepsia 2008; 49: 73-9.
48. Nicoletti A, Bartoloni A, Reggio A, Bartalesi F, Roselli M, Sofia V, et al. Epilepsy, cysticercosis, and toxocariasis. A population-based case-control study in rural Bolivia. Neurology 2002; 58: 1256-61.
49. Garcia HH, Modi M. Helminthic parasites and seizures. Epilepsia 2008; 49 (Suppl 6): S25-32.
50. Marsh K, Forster D, Waruiru C. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332: 1399-404.
51. Kochar DK, Shubhakaran, Kumawar BL, Kochar SK, Halwai M, Makkar RR, et al. Cerebral malaria in Indian adults: a prospective study of 441 patients from Bikaner, north-west India. J Assoc Physicians India 2002; 50: 234-41.
52. Aleem MA. Epilepsy in malaria. Epilepsia 2005; 46: 601.
53. Versteeg AC, Carter JA, Dzombo J, Neville BG, Newton CR. Seizure disorders among relatives of Kenyan children with severe falciparum malaria. Trop Med Int Health 2003; 8: 12-6.
54. Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru K. Seizures and status epilepticus in childhood cerebral malaria. Q J Med 1996; 89: 591-7.
55. Waruiru CM, Newton CR, Forster D, New L, Winstanley P, Mwangi I, et al. Epileptic seizures and malaria in Kenyan children. Tran R Soc Trop Med Hyg 1996; 90: 152-5.
56. Ngoungou EB, Dulac O, Poudiougou B, Druet-Cabanac M, Dicko A, Mamadou Traore A, et al. Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia 2006; 47: 873-9.
57. Ngoungou EB, Koko J, Druet-Cabanac M, Assengone-Zeh-Nguema Y, Launay MN, Engohang E, et al. Cerebral malaria and sequelar epilepsy: first matched case-control study in Gabon. Epilepsia 2006; 47: 2147-53.
58. Carter JA, Neville BG, White S, Ross AJ, Otieno G, Mturi N, et al. Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia 2004; 45: 978-81.
59. Gagandeep-Singh G, Prabhakar S. The association between central nervous system (CNS) infections and epilepsy: epidemiological approaches and microbiological and epileptological perspectives. Epilepsia 2008; 49 (Suppl 6): S2-7.
60. Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomized, controlled intervention study. Lancet 2000; 355: 701-6.
61. Carod-Artal FJ. Complicaciones neurológicas de la enfermedad de Chagas. Enf Emerg 2009; 11 (Supl 1): S34-7.
62. Carod-Artal FJ. Stroke: a neglected complication of American trypanosomiasis (Chagas' disease). Trans R Soc Trop Med Hyg 2007; 101: 1075-80.